Educating Recent Updates on Metastatic Non-small Cell Lung Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Metastasis".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 315
Special Issue Editors
Interests: non-small cell lung cancer; lung adenocarcinoma; pancreatic ductal adenocarcinoma; tumor microenvironment; cancer metastasis; cancer epigenetics; post-translational modification of proteins
Interests: stem cells/cancer stem cells; non-coding RNAs; therapy resistance cancer; transgenesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent updates on metastatic non-small cell lung cancer (NSCLC) delve into intricate aspects of lung adenocarcinomas and squamous cell carcinomas, investigating tumor microenvironment dynamics, epithelial to mesenchymal transition, and the role of desmoplasia towards lung cancer metastasis. Exploring tumor matrix biology, epigenetic modulation influencing tumor metastasis, and/or post-translational modifications of certain key tumorigenic factors adds depth to understanding the progression of cancer. Additionally, insights into the failure of immune surveillance mechanisms facilitating immune escape give a comprehensive understanding of the disease. Collectively, these recent findings in the field will enhance our grasp on the molecular intricacies driving metastatic NSCLC, paving the possible way for future advancements in the diagnosis of the disease and therapy.
Dr. Biswarup Saha
Dr. Hifzur R Siddique
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- non-small cell lung cancer
- lung adenocarcinoma
- lung squamous cell carcinoma
- tumor microenvironment (TME)
- epithelial to mesenchymal transition (EMT)
- cancer metastasis
- desmoplasia
- tumor matrix biology
- epigenetic modulations leading cancer metastasis
- post-translational modifications (PTMs)
- immune evasion
